A CLINICAL TRIAL ON THE EFFICACY OF IMOD IN AIDS PATIENTS

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

MOHRAZ M.; KHEYR ANDISH PARASTOU; AFSAR KAZEROUNI P.; DAVARPANAH M.A.; SHAH HOSSEINI MOHAMMAD HASAN; MAHDAVIAN B.; VAZIRI S.; KAMALI K.; KHORAM KHOURSHID H.R.; HESHMAT RAMIN; FARHADI M.; GHARIB DOUST F.; SHAHRYARI S.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: DARU Journal of Pharmaceutical Sciences Year:2009 | Volume:17 | Issue:4 Page(s): 277-284

Download Full-Text

View:

559

Download:

241

Cites:

Information Journal Paper

Title

A CLINICAL TRIAL ON THE EFFICACY OF IMOD IN AIDS PATIENTS

Author(s)

Keywords

HIV/AIDS

IMOD™

SETARUD

PHASE II

RANDOMIZED CLINICAL TRIAL

Abstract

Background and the purpose of the study: Following the phase I clinical trial of the herbal drug IMOD™ in HIV/AIDS patients, further studies were required to assess the drug efficacy and side effects. Therefore its safety and efficacy in HIV infected patients in a PHASE II were examined, and clinical trial PHASE III were designed. Methods: This study was conducted in three stages. In the first stage six patients who were resistant to highly active anti retroviral therapy (HAART) regimen were chosen and offered therapy with SETARUD. Subsequently another group of 27 patients with CD4 count less than 350 but without AIDS defining criteria were enrolled to the study and randomly assigned to intervention. In the third stage a double-center RANDOMIZED CLINICAL TRIAL was conducted at two independent research centers and universities of Iran. Seventy patients were recruited and randomly allocated into groups, called “control” and SETARUD groups, using a balanced block randomization method. The main outcome measure was CD4 count. Patients were observed and thoroughly examined (Clinical and laboratory) for six months. Results: In stages I and II, the mean CD4 count gradually increased within 3 and 6 months intervals. In the stage III the baseline of CD4 counts and other characteristics between two groups were quite similar. The mean increase in CD4 count in SETARUD group was about 2-3 fold higher than controls. This effect was much more pronounced in a subgroup of patients with a baseline CD4 count of 200-400 (168 vs. 65, 203 vs. 58, 299 vs. 143 and 285 vs. 109, for time intervals of follow-up, respectively) (p<0.001).Conclusion: There was a significant improvement in the immune system of HIV patients receiving SETARUD therapy by increase in the CD4 count to the higher and more protective level in most subjects. Considering results of the safety tests and reports of the durability of the SETARUD effects the use this drug in HIV patients, especially at the pre-AIDS period, as a therapeutic vaccine to slow down the progression of the disease, is recommended.

Cites

NEUROPROTECTIVE EFFECTS OF HERBAL EXTRACT (ROSA CANINA, TANACETUM VULGARE AND URTICA DIOICA) ON RAT MODEL OF SPORADIC ALZHEIMER’S DISEASE

References

No record.

Cite

APA: Copy

MOHRAZ, M., KHEYR ANDISH, PARASTOU, AFSAR KAZEROUNI, P., DAVARPANAH, M.A., SHAH HOSSEINI, MOHAMMAD HASAN, MAHDAVIAN, B., VAZIRI, S., KAMALI, K., KHORAM KHOURSHID, H.R., HESHMAT, RAMIN, FARHADI, M., GHARIB DOUST, F., & SHAHRYARI, S.. (2009). A CLINICAL TRIAL ON THE EFFICACY OF IMOD IN AIDS PATIENTS. DARU JOURNAL OF PHARMACEUTICAL SCIENCE, 17(4), 277-284. SID. https://sid.ir/paper/275522/en

Vancouver: Copy

MOHRAZ M., KHEYR ANDISH PARASTOU, AFSAR KAZEROUNI P., DAVARPANAH M.A., SHAH HOSSEINI MOHAMMAD HASAN, MAHDAVIAN B., VAZIRI S., KAMALI K., KHORAM KHOURSHID H.R., HESHMAT RAMIN, FARHADI M., GHARIB DOUST F., SHAHRYARI S.. A CLINICAL TRIAL ON THE EFFICACY OF IMOD IN AIDS PATIENTS. DARU JOURNAL OF PHARMACEUTICAL SCIENCE[Internet]. 2009;17(4):277-284. Available from: https://sid.ir/paper/275522/en

IEEE: Copy

M. MOHRAZ, PARASTOU KHEYR ANDISH, P. AFSAR KAZEROUNI, M.A. DAVARPANAH, MOHAMMAD HASAN SHAH HOSSEINI, B. MAHDAVIAN, S. VAZIRI, K. KAMALI, H.R. KHORAM KHOURSHID, RAMIN HESHMAT, M. FARHADI, F. GHARIB DOUST, and S. SHAHRYARI, “A CLINICAL TRIAL ON THE EFFICACY OF IMOD IN AIDS PATIENTS,” DARU JOURNAL OF PHARMACEUTICAL SCIENCE, vol. 17, no. 4, pp. 277–284, 2009, [Online]. Available: https://sid.ir/paper/275522/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops